
Anwipharmasp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 61 days late).
- 202514/07/2026
- 202412/02/2025
- 202313/07/2024
- 202222/06/2023
- 202114/09/2022
- 202008/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Anwipharma holds 2 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2012.
| Mark | Protected until | |
|---|---|---|
| ANWIPHARMA(word) | Sep 14, 2032 | |
| ANWIFARMA(word) | Sep 14, 2032 | |
| Pharmitis(word) | – | |
| RP RECEPTARIUM POLONICUM | – |
Authorized Representatives
Manner of representation
If a multi-member management board is appointed, each member of the management board individually is authorized to conduct the affairs of the company and represent the company (independent representation).
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Witold Witkowskiage 57 | 46 | $12,425.72 | 92% |
Others | 4 | $1,080.50 | 8% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-11-07.
69 1090 1072 0000 0001 3700 4297
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $20,435.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $111$111 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | PREZYDENT MIASTA BYDGOSZCZ | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $114$114 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Proxissp. z o.o. | $156,492.56 | proxis.pl | ||
| Pharmaxi Polandsp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Ośrodek Badań Klinicznych Labmedsp. z o.o. | $147,652.43 | labmed.biz.pl | ||
| Meet Commercesp. z o.o. | $147,569.45 | meetcommerce.com | ||
| SN Biotech Technologiessp. z o.o. + limited partnership | $144,861.78 | snbiotech.com | ||
| Chemlabsp. z o.o. | $144,354.49 | chemlab.com.pl | ||
| Siejesiesp. z o.o. | $143,906.31 | siejesie.pl | ||
| Wielkopolskie Centrum Medycyny Podróżysp. z o.o. | $143,668.07 | medtrop.pl | ||
| Molossp. z o.o. | $132,151.67 | molos.pl | ||
| Natalabsp. z o.o. | $117,374.31 | natalab.eu |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-29 | PKD change (Removed: 31 codes) | |
| 2012-10-23 | Entered in the register |
FAQ
Last updated: 2026-07-15